Zhou, Wei
Wang, Tao
Zhu, Lingjuan
Shi, Yumeng
Yu, Chao
Bao, Huihui
Cheng, Xiaoshu
Funding for this research was provided by:
Jiangxi Provincial Drug Administration Science and Technology Project (2023JS26)
National Natural Science Foundation of China (82460670)
Article History
Received: 21 November 2024
Accepted: 11 March 2025
First Online: 18 March 2025
Declarations
:
: This research was approved by the Ethics Committees of the Biomedical Institute of Anhui Medical University (CH1059). The website of Chinese Clinical Trial Registry approved (2018-07-20) the current study with ChiCTR number: ChiCTR1800017274, URL:, and this study was conducted under the Declaration of Helsinki. After being informed of the benefits and risks of research, participants signed written consent.
: Not applicable.
: The authors declare no competing interests.